DISPHARMA_RETAIL_LIMITED - Accounts

Company Registration No. 02516188 (England and Wales)
DISPHARMA RETAIL LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017
DISPHARMA RETAIL LIMITED
COMPANY INFORMATION
Directors
Mr S Fazal
Mr M G Fazal
Mr N Fazal
Mr I H Fazal
(Appointed 17 June 2016)
Secretary
Mr M G Fazal
Company number
02516188
Registered office
Unit 1 Century Park
Garrison Lane
Birmingham
West Midlands
England
B9 4NZ
Auditor
FLS Accounting Solutions Limited T/A SP Vinshaw
UCB House
3 George Street
Watford
Hertfordshire
England
WD18 0BX
Business address
Unit 1 Century Park
Garrison Lane
Birmingham
West Midlands
England
B9 4NZ
DISPHARMA RETAIL LIMITED
CONTENTS
Page
Statement of comprehensive income
1
Balance sheet
2
Statement of changes in equity
3
Notes to the financial statements
4 - 12
DISPHARMA RETAIL LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2017
- 1 -
2017
2016
£
£
(Loss)/profit for the year
(47,285)
55,378
Other comprehensive income
-
-
Total comprehensive income for the year
(47,285)
55,378
DISPHARMA RETAIL LIMITED
BALANCE SHEET
AS AT
31 MARCH 2017
31 March 2017
- 2 -
2017
2016
Notes
£
£
£
£
Fixed assets
Intangible assets
3
881,122
1,006,996
Tangible assets
4
802,550
876,443
Investments
5
52
52
1,683,724
1,883,491
Current assets
Stocks
263,461
332,304
Debtors
7
1,467,634
1,614,554
Cash at bank and in hand
2,779
3,352
1,733,874
1,950,210
Creditors: amounts falling due within one year
8
(1,758,382)
(1,892,703)
Net current (liabilities)/assets
(24,508)
57,507
Total assets less current liabilities
1,659,216
1,940,998
Creditors: amounts falling due after more than one year
9
(1,007,969)
(1,242,466)
Net assets
651,247
698,532
Capital and reserves
Called up share capital
10
450,000
450,000
Profit and loss reserves
201,247
248,532
Total equity
651,247
698,532

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the board of directors and authorised for issue on 18 December 2017 and are signed on its behalf by:
Mr S Fazal
Director
Company Registration No. 02516188
DISPHARMA RETAIL LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2017
- 3 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2015
450,000
193,153
643,153
Year ended 31 March 2016:
Profit and total comprehensive income for the year
-
55,378
55,378
Balance at 31 March 2016
450,000
248,532
698,532
Year ended 31 March 2017:
Loss and total comprehensive income for the year
-
(47,285)
(47,285)
Balance at 31 March 2017
450,000
201,246
651,246
DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017
- 4 -
1
Accounting policies
Company information

Dispharma Retail Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 1 Century Park, Garrison Lane, Birmingham, West Midlands, England, B9 4NZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 5 -
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
2% straight line
Land and buildings Leasehold
Over the life of the lease
Fixtures, fittings & equipment
25% straight line
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 6 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 7 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

 

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

1.12
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
1
Accounting policies
(Continued)
- 8 -
1.13
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.14
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.15
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to the profit and loss account so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 22 (2016 - 25).

3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2016 and 31 March 2017
2,388,009
Amortisation and impairment
At 1 April 2016
1,381,013
Amortisation charged for the year
125,874
At 31 March 2017
1,506,887
Carrying amount
At 31 March 2017
881,122
At 31 March 2016
1,006,996
DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
- 9 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2016
732,339
869,408
1,601,747
Additions
3
10,525
10,528
Disposals
-
(38,706)
(38,706)
At 31 March 2017
732,342
841,227
1,573,569
Depreciation and impairment
At 1 April 2016
161,414
563,890
725,304
Depreciation charged in the year
14,755
68,082
82,837
Eliminated in respect of disposals
-
(37,122)
(37,122)
At 31 March 2017
176,169
594,850
771,019
Carrying amount
At 31 March 2017
556,173
246,377
802,550
At 31 March 2016
570,926
305,517
876,443
5
Fixed asset investments
2017
2016
£
£
Investments
52
52
Movements in fixed asset investments
Shares in group undertakings
Other investments other than loans
Total
£
£
£
Cost or valuation
At 1 April 2016 & 31 March 2017
51
1
52
Carrying amount
At 31 March 2017
51
1
52
At 31 March 2016
51
1
52
6
Significant undertakings
DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
6
Significant undertakings
(Continued)
- 10 -

The company also has significant holdings in undertakings which are not consolidated:

Name of undertaking
Registered
Nature of business
Class of
% Held
office
shares held
Direct
Indirect
Great Wood Pharmacy Limited
England and Wales
Retail Chemist
Ordinary
50.00
Washwood Heath Healthcare Ltd
England and Wales
Retail Chemist
Ordinary
25.00
Pharmaco Dudley Limited
England and Wales
Retail Chemist
Ordinary
100.00
The aggregate capital and reserves and the result for the year of significant undertakings noted above was as follows:
Name of undertaking
Profit/(Loss)
Capital and Reserves
£
£
Great Wood Pharmacy Limited
52,631
58,418
Washwood Heath Healthcare Ltd
(87,905)
(93,353)
Pharmaco Dudley Limited
4,170
4,171
7
Debtors
2017
2016
Amounts falling due within one year:
£
£
Trade debtors
397,597
621,056
Amounts owed by group undertakings
979,276
876,119
Other debtors
90,761
117,379
1,467,634
1,614,554
8
Creditors: amounts falling due within one year
2017
2016
£
£
Bank loans and overdrafts
377,606
602,300
Trade creditors
622,795
683,353
Amounts due to group undertakings
629,308
431,920
Corporation tax
125
2,400
Other taxation and social security
7,152
6,373
Other creditors
121,396
166,357
1,758,382
1,892,703
DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
- 11 -
9
Creditors: amounts falling due after more than one year
2017
2016
£
£
Bank loans and overdrafts
1,006,532
1,235,864
Other creditors
1,437
6,602
1,007,969
1,242,466

The long-term loans are secured by fixed and floating charges over the assets of the company.

10
Called up share capital
2017
2016
£
£
Ordinary share capital
Issued and fully paid
450,000 Ordinary shares of £1 each
450,000
450,000
450,000
450,000
11
Audit report information

As the income statement has been omitted from the filing copy of the financial statements the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

The auditor was FLS Accounting Solutions Limited T/A SP Vinshaw.
DISPHARMA RETAIL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2017
- 12 -
12
Related party transactions

The company has taken advantage of exemption under section 33.1A of FRS 102, from the requirement to disclose transactions with wholly owned members of the group.

 

13
Controlling party

The immediate parent company is G.F. Corporation Limited, a company registered in England and Wales. In the opinion of the directors, the ultimate controlling party is the Fazal Family.

14
Contingent liabilities

The company has given guarantees and charges over its properties in favour of other group companies in respect of certain borrowings of those companies.

2017-03-312016-04-01falseCCH SoftwareCCH Accounts Production 2017.400No description of principal activity18 December 2017This audit opinion is unqualifiedSadikali Premji025161882016-04-012017-03-3102516188bus:Director12016-04-012017-03-3102516188bus:CompanySecretaryDirector12016-04-012017-03-3102516188bus:Director22016-04-012017-03-3102516188bus:Director32016-04-012017-03-3102516188bus:CompanySecretary12016-04-012017-03-3102516188bus:RegisteredOffice2016-04-012017-03-31025161882015-04-012016-03-31025161882017-03-31025161882016-03-3102516188core:NetGoodwill2017-03-3102516188core:NetGoodwill2016-03-3102516188core:LandBuildings2017-03-3102516188core:OtherPropertyPlantEquipment2017-03-3102516188core:LandBuildings2016-03-3102516188core:OtherPropertyPlantEquipment2016-03-3102516188core:CurrentFinancialInstruments2017-03-3102516188core:CurrentFinancialInstruments2016-03-3102516188core:Non-currentFinancialInstruments2017-03-3102516188core:Non-currentFinancialInstruments2016-03-3102516188core:ShareCapital2017-03-3102516188core:ShareCapital2016-03-3102516188core:ShareCapitalcore:RestatedAmount2015-03-3102516188core:RetainedEarningsAccumulatedLossescore:RestatedAmount2015-03-3102516188core:RestatedAmount2015-03-3102516188core:RetainedEarningsAccumulatedLosses2016-03-3102516188core:ShareCapitalOrdinaryShares2017-03-3102516188core:ShareCapitalOrdinaryShares2016-03-3102516188core:Goodwill2016-04-012017-03-3102516188core:LandBuildingscore:OwnedOrFreeholdAssets2016-04-012017-03-3102516188core:LandBuildingscore:LeasedAssetsHeldAsLessee2016-04-012017-03-3102516188core:FurnitureFittings2016-04-012017-03-3102516188core:MotorVehicles2016-04-012017-03-3102516188core:NetGoodwill2016-03-3102516188core:NetGoodwill2016-04-012017-03-3102516188core:LandBuildings2016-03-3102516188core:OtherPropertyPlantEquipment2016-03-31025161882016-03-3102516188core:LandBuildings2016-04-012017-03-3102516188core:OtherPropertyPlantEquipment2016-04-012017-03-3102516188bus:OrdinaryShareClass12016-04-012017-03-3102516188bus:OrdinaryShareClass12017-03-3102516188bus:PrivateLimitedCompanyLtd2016-04-012017-03-3102516188bus:FRS1022016-04-012017-03-3102516188bus:Audited2016-04-012017-03-3102516188bus:SmallCompaniesRegimeForAccounts2016-04-012017-03-3102516188bus:FullAccounts2016-04-012017-03-31xbrli:purexbrli:sharesiso4217:GBP